If you didn’t see the original news, back in May, Sen. Ron Johnson requested clarification and justification of the FDA’s deeming vapor regulations. Sen. Ron Johnson also inquired about whether the FDA would consider revising the deeming regulations if sufficient evidence emerged regarding the harm reduction rates of electronic cigarettes. The FDA obviously has not seen Public Health England’s study, or the report released by the Royal College of Physicians. In the first letter, the requested date for response was May 31st. The 31st came and passed, but the FDA remained silent and did not even acknowledge the request.

Since the initial letter was ignored, Sen. Jonson wrote a follow up request on June 6, 2016.

“Since I sent my initial letter to you, I have heard from many small-business owners who manufacture or sell e-cigarette products,” Johnson wrote in the letter. These job creators have contacted my office expressing their grave concerns about the FDA’s regulatory overreach. They fear that the FDA’s e-cigarette rule will force them out of business by requiring them to complete costly and time-consuming premarket applications for each e-cigarette product. In addition, a large number of individuals have contacted my office to tell their stories about how they use or have used e-cigarettes to quit smoking. They do not want the FDA to make access to e-cigarettes more difficult for them—or others like them—as they fight to kick an addiction to smoking.”

If you would like to read the follow up letter in its entirety, you can download it here.

In the follow up letter, Sen. Ron Johnson states that the committee may be forced to take further action if an adequate response is not received by 5:00 p.m on June, 20 2016. The FDA only has 72 hours to reply with an adequate response.

If you haven’t already, please reach out to Sen. Ron Johnson and give thanks for reasonable response to the FDA’s deeming regulations on vapor products. You can reach out to the Senator on twitter, or you can visit his website.

Do YOU think the FDA will respond? Let us know in the comments below!